EN DE
Watch Oneview Healthcare Plc for free: we tell you when fair value or trend changes.
Data-driven stock valuation

Oneview Healthcare Plc (ONE) fair value: what the stock is really worth

As of Nov 11, 2026: fair value (intrinsic value) of Oneview Healthcare Plc stock A$0.09, price A$0.14, that is 32.7% below the price, quality 32 out of 100. Rating: overvalued. The value is an estimate: none of our valuation models currently carries, it draws on revenue and assets compared with similar companies. Updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Healthcare AU · Based in Ireland · ISIN AU000000ONE9

OH Oneview Healthcare Plc logo Thin data Nov 10, 2026

Oneview Healthcare Plc

ONE · AU
Expensive, weak quality

Our calculation puts a fair price 33% below what the stock costs today.

Low debt
Expensive Growth (revenue 5y +10.9 %/yr in EUR)
Revenue last quarter 14% below a year ago.
Fair value A$0.0909 · Overvalued
Quality 32/100
Loss-making · -91.5% net margin (TTM)
Negative free cash flow
Trails peers (1/10)
Narrow moat 12/100 · thin data
Thin data
Estimate
Watch Oneview Healthcare Plc for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

A$0.4600 A$0.0620 Fair Value A$0.0909 Aug 2021 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 10, 2026.

How to read this chart

60‑month range A$0.0620 – A$0.4600 · fair‑value band A$0.0681 – A$0.1136 · the A$0.1350 price screens above the A$0.0909 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 10, 2026.

Follow Oneview Healthcare in your weekly email

Every Wednesday you see whether Oneview Healthcare is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Oneview Healthcare PLC develops and sells software services for the healthcare sector in Ireland, the United States, Australia, the Middle East, and Asia.

Show moreShow less

The company provides patient experience, care team experience, and health system and hospital solutions; and system integrations for HER/EMP/PAS, virtual care, interpretations, middleware, clinical communications, dietary, IoT: RTLS and building automation, patient education and portals, entertainment and gaming, calming and distraction, and consumer streaming and social.

It also offers secure software development lifecycles, data classification, and third-party penetration testing services. The company was founded in 2008 and is based in Dublin, Ireland.

Stock analysis

Oneview Healthcare Plc (ONE) currently trades at A$0.1350, while our estimate is A$0.0909, 33% below the price, so the stock looks overvalued today.

Show more

Valuation

None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.

Scenario range: A$0.0681 (bear) to A$0.1136 (bull), the price of A$0.1350 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 32/100 (below-average quality), in the Healthcare sector.

Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.

Oneview Healthcare Plc reported revenue of €11.9M in FY2025 versus €9.7M in FY2021, a compound +5.2%/yr. Reported net income was −€12.5M in FY2025.

Key figures

Market cap A$123M (≈ $84.8M) Micro · P/S ratio 11.1 · EPS (TTM) A$−0.0200 · Net margin −105% · Return on equity −146% · Return on assets (EBIT) −55.3% (5-year average) · Operating margin −103% · Revenue (TTM) €11.1M.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 12 out of 100 (low confidence).

What moves the price

The share trades about 66% below its 52-week high and 29% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Healthcare peers we cover trades at −35% fair-value upside, at −33%, ONE screens cheaper than that median.

Fair Value

Bear A$0.0681 Fair Value A$0.0909 Bull A$0.1136
Price A$0.1350 · Downside -32.7%
Estimate. None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.

Quality Score breakdown

Overall quality 32/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 28
How much profit the company makes from its sales and capital
Quality Growth 57
Are margins and returns getting better?
Cashflow 4
Do the profits arrive as real cash?
Financial strength 55
Debt, balance sheet and risk of trouble
Investment 60
Does it invest with discipline instead of growing at any price?
Low Volatility 31
How calm the share price moves, does not count
Price momentum 14
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 5
Distance to the 52-week high, does not count
New shares 0
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 37/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
+20.6%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+10.2%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+10.9%
Start year 2020 (pandemic). Over 10 years: +13.2% a year
Revenue growth 13 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+48.5%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−123.2% (2020) → −92.1% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed

ONE screens overvalued: fair value 33% below the price. Compare with Veeva Systems Inc →

Compare Oneview Healthcare Plc with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Health Information Services · 141 stocks

Beats the industry median on 1/9 measures
Overall it trails its industry peers.
Valuation
Quality Score 32 · Bottom 25%
Fair Value upside −32.7% · Below median
Profitability
Return on assets −80.8% · Bottom 25%
Net margin (12 months) −91.5% · Bottom 25%
Operating margin (12 months) −102.8% · Bottom 25%
Growth and dividend
Revenue growth (quarter YoY) −13.5% · Bottom 25%
Balance sheet
Debt / equity 0.03× · Below median

Valuation Multiplesvs Health Information Services median · lower = cheaper

P/B 20.83× · Priciest 25%
P/S (12 months) 6.81× · Priciest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)0 · sector 13
FUTURE (revenue growth)0 · sector 45
PAST (return on equity)0 · sector 0
HEALTH (low debt)99 · sector 98
DIVIDEND (yield)0 · sector 46

VALUE 0: the price sits above our fair-value range.

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Health Information Services stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Doximity, Inc DOCS $32.42 $36.16 +12% vs ONE
Veeva Systems Inc VEEV $305.55 $337.04 +10% vs ONE
HealthEquity, Inc HQY $103.54 $112.32 +8% vs ONE
Waystar Holding WAY $29.30 $29.10 −1% vs ONE
Tempus AI, Inc TEM $80.54 $52.58 −35% vs ONE
HeartFlow, Inc HTFL $55.80 $34.82 −38% vs ONE
Hinge Health, Inc HNGE $123.23 $51.25 −58% vs ONE
Pro Medicus Limited PME A$207.31 A$85.12 −59% vs ONE
BrightSpring Health Services, Inc BTSG $72.49 $25.72 −65% vs ONE
XtalPi Holdings 2228 HK$6.37 HK$1.53 −76% vs ONE

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend StocksUndervalued 52-Week Low StocksStocks for 2027: Large Companies Below Fair Value

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Free calculator Peter Lynch Fair Value Formula &…Free calculator
Run the numbers yourself: free valuation calculators
DCF CalculatorP/E Ratio CalculatorPEG Ratio CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorIntrinsic ValueIntrinsic vs Extrinsic ValueP/E Ratio by Sector
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Oneview Healthcare Plc: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "Oneview Healthcare Plc Fair Value". https://www.fairvalue-calculator.com/stock/ONE.AU

Frequently asked questions

Is Oneview Healthcare Plc (ONE) overvalued or undervalued?
As of Nov 10, 2026, our estimate of fair value is A$0.0909 versus a price of A$0.1350, about 33% lower (overvalued).
What is the fair value of ONE?
Our estimate for Oneview Healthcare Plc is A$0.0909 (as of Nov 10, 2026), built from audited fundamentals. The current price: A$0.1350.
What is the quality score of ONE?
Oneview Healthcare Plc has a Quality Score of 32/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Oneview Healthcare Plc (ONE)?
Our calculated price target is the estimate of A$0.0909 (as of Nov 10, 2026). Cautious scenario A$0.0681, optimistic scenario A$0.1136. It is an estimate from revenue and assets compared with similar companies, because none of our valuation models currently carries, not an analyst target.
What is the Oneview Healthcare Plc stock forecast for 2026?
Our estimate puts fair value at A$0.0909, about 33% lower versus a price of A$0.1350 (overvalued). Cautious scenario A$0.0681, optimistic scenario A$0.1136. The calculation is refreshed regularly with new filings.
What is the revenue of Oneview Healthcare Plc (ONE)?
Oneview Healthcare Plc reported trailing-twelve-month revenue of about €11.1M (latest available figure, as of Nov 10, 2026).
What is the intrinsic value of Oneview Healthcare Plc (ONE)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Oneview Healthcare Plc it is A$0.0909 per share (as of Nov 10, 2026), against a price of A$0.1350.
Is Oneview Healthcare Plc stock overvalued or undervalued in 2026?
As of Nov 10, 2026, ONE trades above its calculated fair value: price A$0.1350, fair value A$0.0909, a gap of about −33% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of ONE?
No. The price is what the market pays today (A$0.1350); the fair value is what the company's own numbers justify (A$0.0909). For Oneview Healthcare Plc the two are A$0.0441 per share apart. That gap is exactly why we show both numbers side by side.
How much is Oneview Healthcare Plc worth?
The market values Oneview Healthcare Plc at about A$123M (market capitalisation, as of Nov 10, 2026). Per share that is A$0.1350; our models calculate a fair value of A$0.0909 per share.
What do the bullish and bearish scenarios say about ONE?
Our models span a range for Oneview Healthcare Plc: cautious scenario A$0.0681, base A$0.0909, optimistic A$0.1136 per share (as of Nov 10, 2026, price A$0.1350). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Oneview Healthcare Plc (ONE)?
Balance-sheet figures for Oneview Healthcare Plc (as of Nov 10, 2026): return on equity −146.1%, debt of 0.03 per unit of equity. They feed the Quality Score of 32/100, which measures business quality independently of the share price.
How far is ONE from its 52-week high?
Oneview Healthcare Plc trades at A$0.1350, about 66% below its 52-week high of A$0.4000 and 29% above the low of A$0.1050 (as of Nov 11, 2026). Distance from the high says nothing about value: that is what the fair value of A$0.0909 is for.
Which stocks are comparable to Oneview Healthcare Plc?
From the same area (Healthcare) we also value Veeva Systems Inc, Pro Medicus Limited, BrightSpring Health Services, Inc, Tempus AI, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Oneview Healthcare Plc stock attractive at the current price?
The data as of Nov 10, 2026: price A$0.1350, calculated fair value A$0.0909 (−33%), Quality Score 32/100. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
Is it still worth investing in stocks now?
The global stock market currently sits 15.1% above its aggregate fair value. Oneview Healthcare Plc itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Oneview Healthcare Plc (ONE)?
The closing price on Nov 11, 2026 was A$0.1350. Our estimate is A$0.0909, about 33% lower (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Oneview Healthcare Plc right now?
The price sits above even our optimistic bull case (A$0.1136). The favourable scenario is already priced in. Weak quality (32/100) and above fair value at the same time, the margin of safety is missing on both counts. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.

Key figures of Oneview Healthcare Plc

How large is the market capitalisation of Oneview Healthcare Plc (ONE)?
The market capitalisation of Oneview Healthcare Plc is A$123M (≈ $84.8M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Oneview Healthcare Plc (ONE)?
The price-to-sales ratio of Oneview Healthcare Plc is 11.1 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Oneview Healthcare Plc (ONE)?
Earnings per share at Oneview Healthcare Plc are A$−0.0200. Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Oneview Healthcare Plc (ONE)?
The net margin of Oneview Healthcare Plc is −105% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Oneview Healthcare Plc (ONE)?
The return on equity (ROE) of Oneview Healthcare Plc is −146% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Oneview Healthcare Plc (ONE)?
On an EBIT basis the return on assets of Oneview Healthcare Plc is −55.3% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Oneview Healthcare Plc (ONE)?
The operating margin of Oneview Healthcare Plc is −103% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Oneview Healthcare Plc (ONE)?
Revenue at Oneview Healthcare Plc is growing −13.5% versus a year earlier (3y avg +10.2%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much free cash flow does Oneview Healthcare Plc (ONE) generate?
The free cash flow of Oneview Healthcare Plc is −€8.4M (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net cash does Oneview Healthcare Plc (ONE) hold?
Oneview Healthcare Plc holds more cash than debt, €2.6M net (fiscal year 2025). The company holds more cash than debt, a safety cushion.
Free · no account needed

Watch Oneview Healthcare Plc in the live analysis

One click puts Oneview Healthcare Plc on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.